Valneva SE (VALN) Net Margin (2021 - 2026)
Valneva SE (VALN) posted Net Margin of 76.68% for Q1 2026, up 41.05% sequentially from 130.08% in Q4 2025, and down 6457.0% YoY from 1.21% in Q1 2025.
Analysis
Valneva SE (VALN) Net Margin (2021 - 2026) Analysis & Trends
Valneva SE has reported Net Margin for 6 years, with the latest figure at 76.68% in Q1 2026.
- Quarterly Net Margin fell 6457.0% year-over-year to 76.68% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 96.06% (down 6197.0% YoY) and the FY2025 annual result came in at 72.97%, down 8113.0% from the prior year.
- Net Margin advanced to 76.68% in Q1 2026 per VALN's latest filing, from 130.08% in the prior quarter.
- Over five years, Net Margin peaked at 208.25% in Q1 2024 and troughed at 221.49% in Q3 2025.
- A 5-year average of 53.53% and a median of 52.69% in 2024 frame the typical range for Net Margin.
- The sharpest annual moves came in 2022 and 2025: Net Margin soared 76476 bps in 2022, then tumbled 22036 bps in 2025.
- Over 5 years, Net Margin stood at 50.58% in 2022, then decreased by 18 bps to 59.45% in 2023, then surged by 62 bps to 22.38% in 2024, then sank by 481 bps to 130.08% in 2025, then surged by 41 bps to 76.68% in 2026.
- According to Business Quant data, Net Margin over the past three periods registered 76.68%, 130.08%, and 221.49% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 32.99% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 30.23% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 31.16% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -539.31% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 13.90% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 12.74% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 12.09% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -3.12% |
| 10 | Valneva SE | 578.54 Mn | 437.28 Mn | 1.86 Mn | 0.00% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.00% |
| Mar 31, 2026 | 0.00% |
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | 0.00% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | 0.00% |
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | 96.00% |
| Jun 30, 2022 | -198.82% |
| Mar 31, 2022 | -114.60% |
| Dec 31, 2021 | 63.29% |
| Sep 30, 2021 | -705.20% |